Cellectis S.A. - American Depositary Shares — Financial Statements (NASDAQ:CLLS) | MetaTrader

Open full chart

News

Jefferies assumes coverage on Cellectis stock with Buy rating

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Brunswick (NYSE:BC), Cellectis (NASDAQ:CLLS)

Clear Street initiates Cellectis stock with Buy rating on CAR-T potential

Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This (CLLS)

Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Allogene Therapeutics (NASDAQ:ALLO), Cellectis (NASDAQ:CLLS)

Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Argo Blockchain (NASDAQ:ARBK), Ascent Solar Technologies (NASDAQ:ASTI)

Allogene stock rises after favorable arbitration ruling reaffirms therapy rights

Arbitration ruling partially terminates Cellectis-Servier license agreement

Cellectis’ Allogeneic CAR-T Potential Still Justifies A “Buy” (NASDAQ:CLLS)

Why Cellectis Stock Is Trading Higher Today - Cellectis (NASDAQ:CLLS)

Citizens maintains Cellectis stock rating with $8 target ahead of ASH update

Duke Energy, KKR, Constellation Energy to report Friday, many more